Tolvaptan

Tolvaptan is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.

Tolvaptan is a selective, oral vasopressin V₂-receptor antagonist (vaptant) that blocks the effects of vasopressin (antidiuretic hormone) in the kidney. It promotes aquaresis (free water excretion) without significant electrolyte loss and is approved for hyponatremia and autosomal dominant polycystic kidney disease (ADPKD).

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Hyponatremia treatment (SIADH)
• Autosomal dominant polycystic kidney disease (ADPKD)
• Euvolemic and hypervolemic hyponatremia
• Heart failure-related fluid retention

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings